Paper Details

Paper Title

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2022

Bio Mention

Mesh Descriptor

Column Actions